Violation Tracker Individual Record
Date:April 24, 2003
Offense Group:competition-related offenses
Primary Offense:price-fixing or anti-competitive practices
Bristol-Myers Squibbb agreed to pay $55 million to settle multistate litigation alleging it illegally denied consumers access to cheaper, generic versions of its cancer-fighting drug Taxol.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New York
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.